Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Potential human pheromone receptor gene identified

Aug. 31, 2000

Serono to develop protein expression technology with Modex Therapeutics

Aug. 31, 2000

Designer transcription factor used to activate erythropoietin gene

Aug. 24, 2000

British Biotech partners with De Novo for antibacterial drug discovery

Aug. 23, 2000

Lynx Therapeutics enters partnership to identify diabetes-associated SNPs

Aug. 22, 2000

Avanir forms subsidiary to exploit human MAb technology

Aug. 21, 2000

McGill University licenses fungal genomics technology to Mycota Biosciences

Aug. 21, 2000

Anadys signs antifungal collaboration with Pharmacia

Aug. 21, 2000

Screening method based on spectral data offered by NIH for licensing

Aug. 18, 2000

Atrix to use drug delivery technology to develop products for Pfizer

Aug. 17, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
Regulatory actions for July 27, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Alfasigma,...
AACR D3: ONM-421 shows antigen-independent tumor control
BioWorld Science
At the American Association for Cancer Research’s inaugural Drug Discovery and Development conference (AACR D3), Onconano Medicine Inc. presented preclinical data...